Louis McIntyre, MD
Orthopaedic Surgery · Clemmons, NCNPI 1699789347
Payments from drug & device makers
What this record shows
This record is dominated by other: $271,234 of the $418,880 with a category attached, or 64.8%. Zimmer Biomet accounts for 77.0% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $207,819 and has fallen 66.3% since, to $69,987 in 2025. Among orthopaedic surgery clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $3378.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$323K
- Smith+Nephew$61K
- Sanofi-aventis U.S. LLC$21K
- Bioventus LLC$4K
- Maruho Medical, Inc.$4K
- Embody, Inc.$3K
- plus $3K from 8 others
Across 6 payments — averaging $14,329 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pacira Therapeutics, Inc.$82K
- Smith+Nephew$2K
- Sanofi-aventis U.S. LLC$1K
What the payments were for
- Royalty or licence$47,10511%
- Consulting fees$34,7528%
- Speaking & faculty fees$52,17212%
- Travel & lodging$9,9432%
- Food & beverage$3,1821%
- Gifts$4910%
- Other$271,23465%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 23 | $322,575 |
| Smith+Nephew | 64 | $60,645 |
| Sanofi-aventis U.S. LLC | 7 | $21,230 |
| Bioventus LLC | 3 | $4,399 |
| Maruho Medical, Inc. | 3 | $3,788 |
| Embody, Inc. | 4 | $2,989 |
| Pacira Therapeutics, Inc. | 7 | $1,894 |
| Tosoh Bioscience, Inc. | 1 | $491 |
| Arthrex | 5 | $290 |
| Stryker | 1 | $163 |
| Aesculap Biologics, LLC | 1 | $149 |
| Heron Therapeutics, Inc. | 1 | $121 |
| Medical Device Business Services, Inc. | 2 | $80 |
| DJO, LLC | 2 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TAPESTRY$241,227
- Bioinductive Implant with Arthroscopic Delivery System - Medium$33,191
- Healicoil$32,855
- Bone Anchors with Arthroscopic Delivery System$16,162
- NO PRODUCT DISCUSSED$11,429
- SYNVISC$9,720
- Regeneten$7,694
- HEALICOIL REGENESORB$5,250
- NOVOSTITCH$4,733
- XCELL$4,399
- itto CSP$3,788
- REGENESORB$3,750
- Tricera Handpiece$3,500
- Coblation$3,000
- SPATIAL FRAME$3,000
- Double Pump RF$3,000
- Accu-pass$2,750
- Biceptor$2,500
- BIORAPTOR Shoulder$2,500
- ELITE Shoulder$2,500
How this compares
$418,880 in reported general payments places this provider in the 95th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other orthopaedic surgery in Clemmons
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.